Mesenchymal Stem Cells in the Treatment of Burn Wounds

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorThe First Affiliated Hospital of Xinxiang Medical College

About this trial

Burn patients were randomly divided into the low-dose stem cell gel group, the high-dose stem cell gel group, and the placebo group (with only the gel), and received the same treatment under the same conditions simultaneously.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Voluntary participation and signing of the informed consent form;

Burn patients, subjects requiring autologous skin grafting;

Age 18 to 65 years old, gender not restricted;

During this clinical study, single person, single donor skin area (lateral thigh or trunk) treatment;

Disqualifiers

Those allergic to sodium alginate (gel component);

Electric shock injuries, chemical burns, radiation injuries or combined with other traumas;

Subjects with severe systemic diseases (judged by the researchers);

Subjects with uncontrolled hypertension or diabetes (judged by the researchers);

Trial design

Design model

Parallel

Treatments tested in this trial

  • low-dose stem cell gel group

    Combination product

    Using hydrogels containing low-doses of placenta-derived mesenchymal stem cells as wound dressings to promote wound healing in burn patients after thick skin grafting

  • high-dose stem cell gel group

    Combination product

    Using hydrogels containing or without differenthigh-doses of placenta-derived mesenchymal stem cells as wound dressings to promote wound healing in burn patients after thick skin grafting

  • with only the gel

    Other intervention

    Using only hydrogels as wound dressings to promote wound healing in burn patients after thick skin grafting

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: low-dose stem cell gel groupExperimental treatment 1 intervention
Group B: high-dose stem cell gel groupExperimental treatment 1 intervention
Group C: with only the gelPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Re-epithelialization areas

Re-epithelialization will be determined by clinical evaluations and recorded by digital color photographs

Time frame
Up to 6 month
2

Complete burn wound healing

Time (days) to complete re-epithelialization of burned skin. It will be based on clinical evaluations and digital color photographs

Time frame
Up to 12 month

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.